Cellular	O
redox	O
status	O
influences	O
both	O
cytotoxic	O
and	O
NF-kappa	O
B	O
activation	O
in	O
natural	B-cell_type
killer	I-cell_type
cells	I-cell_type
.	O

The	O
role	O
of	O
cellular	O
redox	O
status	O
in	O
both	O
cytotoxic	O
activity	O
and	O
NF-kappa	B-protein
B	I-protein
activation	O
in	O
natural	B-cell_type
killer	I-cell_type
(	I-cell_type
NK	I-cell_type
)	I-cell_type
cells	I-cell_type
was	O
investigated	O
.	O

The	O
results	O
indicate	O
that	O
stimulation	O
of	O
NK	B-cell_type
cells	I-cell_type
,	O
either	O
freshly	O
isolated	O
from	O
peripheral	B-cell_type
blood	I-cell_type
lymphocytes	I-cell_type
(	O
PBL	B-cell_type
)	O
or	O
long-term	B-cell_line
cultured	I-cell_line
NK	I-cell_line
clones	I-cell_line
,	O
with	O
specific	O
cell	O
targets	O
results	O
in	O
an	O
increased	O
binding	O
activity	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
AP-1	B-protein
transcription	B-protein
factors	I-protein
measured	O
by	O
gel	O
retardation	O
.	O

Pretreatment	O
of	O
NK	B-cell_type
cells	I-cell_type
with	O
the	O
antioxidant	O
pyrrolidine	O
dithiocarbarmate	O
(	O
PDTC	O
)	O
leads	O
to	O
the	O
inhibition	O
of	O
NF-kappa	B-protein
B	I-protein
activation	O
but	O
the	O
AP-1	B-protein
binding	O
to	O
DNA	O
was	O
superinduced	O
.	O

The	O
inhibition	O
of	O
NF-kappa	B-protein
B	I-protein
by	O
PDTC	O
paralleled	O
with	O
an	O
inhibition	O
of	O
spontaneous	O
cytotoxicity	O
mediated	O
by	O
NK	B-cell_type
cells	I-cell_type
.	O

Moreover	O
,	O
the	O
inhibitors	O
of	O
serine	B-protein
proteases	I-protein
,	O
N-alpha-tosyl-L-lysine	O
chloromethyl	O
ketone	O
and	O
N-alpha-tosyl-L-phenylalanine	O
chloromethyl	O
ketone	O
,	O
also	O
blocked	O
the	O
cytolytic	O
activity	O
of	O
NK	B-cell_type
cells	I-cell_type
against	O
the	O
sensitive	O
target	O
K562	B-cell_line
.	O

In	O
contrast	O
,	O
NK	O
activity	O
was	O
not	O
affected	O
by	O
pretreatment	O
of	O
the	O
effector	O
cells	O
with	O
the	O
proteasome	B-protein
inhibitor	O
N-acetyl-leu-leu-norleucinal	O
which	O
selectively	O
inhibits	O
NF-kappa	B-protein
B	I-protein
activation	O
.	O

Altogether	O
,	O
these	O
results	O
support	O
the	O
hypothesis	O
that	O
the	O
activation	O
of	O
NK	B-cell_type
cells	I-cell_type
involved	O
transcriptional	O
and	O
post-transcriptional	O
events	O
,	O
and	O
that	O
reactive	O
intermediates	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
molecular	O
processes	O
related	O
with	O
the	O
generation	O
of	O
a	O
cytotoxic	O
response	O
by	O
NK	B-cell_type
cells	I-cell_type
.	O

Immunology	NULL
1997	NULL
90	NULL
455-460	NULL
Cellular	NULL
redox	NULL
status	NULL
influences	NULL
both	NULL
cytotoxic	NULL
and	NULL
NF-xB	NULL
activation	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
M.	NULL
VALLE	NULL
BLAZQUEZ	NULL
,	NULL
*	NULL
I.	NULL
LUQUE	NULL
,	NULL
*	NULL
E.	NULL
COLLANTES	NULL
,	NULL
f	NULL
E.	NULL
ARANDA	NULL
,	NULL
t	NULL
R.	NULL
SOLANA	NULL
,	NULL
*	NULL
J.	NULL
PENA*	NULL
&	NULL
E.	NULL
MUNOZ*	NULL
*Department	NULL
of	NULL
Physiology	NULL
and	NULL
Immunology	NULL
,	NULL
and	NULL
tDepartment	NULL
of	NULL
Medicine	NULL
,	NULL
Medical	NULL
Faculty	NULL
,	NULL
University	NULL
of	NULL
Cordoba	NULL
,	NULL
Spain	NULL
SUMMARY	NULL
The	NULL
role	NULL
of	NULL
cellular	NULL
redox	NULL
status	NULL
in	NULL
both	NULL
cytotoxic	NULL
activity	NULL
and	NULL
NF-	NULL
B	NULL
activation	NULL
in	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
was	NULL
investigated	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
stimulation	NULL
of	NULL
NK	NULL
cells	NULL
,	NULL
either	NULL
freshly	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
or	NULL
long-term	NULL
cultured	NULL
NK	NULL
clones	NULL
,	NULL
with	NULL
specific	NULL
cell	NULL
targets	NULL
results	NULL
in	NULL
an	NULL
increased	NULL
binding	NULL
activity	NULL
of	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
measured	NULL
by	NULL
gel	NULL
retardation	NULL
.	NULL

Pretreatment	NULL
of	NULL
NK	NULL
cells	NULL
with	NULL
the	NULL
antioxidant	NULL
pyrrolidine	NULL
dithiocar-barmate	NULL
(	NULL
PDTC	NULL
)	NULL
leads	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
activation	NULL
but	NULL
the	NULL
AP-1	NULL
binding	NULL
to	NULL
DNA	NULL
was	NULL
superinduced	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
by	NULL
PDTC	NULL
paralleled	NULL
with	NULL
an	NULL
inhibition	NULL
of	NULL
spontaneous	NULL
cytotoxicity	NULL
mediated	NULL
by	NULL
NK	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
inhibitors	NULL
of	NULL
serine	NULL
proteases	NULL
,	NULL
N-x-tosyl-L-lysine	NULL
chloromethyl	NULL
ketone	NULL
and	NULL
N-	NULL
«	NULL
-tosyl-L-phenylalanine	NULL
chloromethyl	NULL
ketone	NULL
,	NULL
also	NULL
blocked	NULL
the	NULL
cytolytic	NULL
activity	NULL
of	NULL
NK	NULL
cells	NULL
against	NULL
the	NULL
sensitive	NULL
target	NULL
K562	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
NK	NULL
activity	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
pretreatment	NULL
of	NULL
the	NULL
effector	NULL
cells	NULL
with	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
N-acetyl-leu-leu-norleucinal	NULL
which	NULL
selectively	NULL
inhibits	NULL
NF-KB	NULL
activation	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
results	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
NK	NULL
cells	NULL
involved	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
events	NULL
,	NULL
and	NULL
that	NULL
reactive	NULL
intermediates	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
molecular	NULL
processes	NULL
related	NULL
with	NULL
the	NULL
generation	NULL
of	NULL
a	NULL
cytotoxic	NULL
response	NULL
by	NULL
NK	NULL
cells	NULL
.	NULL

INTRODUCTION	NULL
Natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
constitute	NULL
a	NULL
small	NULL
population	NULL
of	NULL
cytotoxic	NULL
lymphocytes	NULL
found	NULL
in	NULL
peripheral	NULL
blood	NULL
and	NULL
lymphoid	NULL
tissues	NULL
,	NULL
which	NULL
are	NULL
capable	NULL
of	NULL
killing	NULL
target	NULL
cells	NULL
such	NULL
as	NULL
tumour	NULL
cells	NULL
,	NULL
virus-	NULL
and	NULL
bacteria-infected	NULL
cells	NULL
in	NULL
a	NULL
non-major	NULL
histo-compatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
-restricted	NULL
manner	NULL
without	NULL
previous	NULL
sensitization	NULL
.	NULL

'*	NULL
The	NULL
molecular	NULL
mechanisms	NULL
for	NULL
NK	NULL
cell	NULL
recognition	NULL
and	NULL
activation	NULL
by	NULL
target	NULL
cells	NULL
are	NULL
not	NULL
entirely	NULL
clarified	NULL
.	NULL

NK	NULL
cells	NULL
can	NULL
be	NULL
activated	NULL
to	NULL
lyse	NULL
target	NULL
cells	NULL
through	NULL
the	NULL
Fc	NULL
receptor	NULL
(	NULL
CD16	NULL
)	NULL
and	NULL
the	NULL
CD2	NULL
molecule	NULL
.	NULL
``	NULL

However	NULL
,	NULL
other	NULL
NK	NULL
receptors	NULL
are	NULL
involved	NULL
in	NULL
natural	NULL
killing	NULL
because	NULL
NK	NULL
cells	NULL
lacking	NULL
expression	NULL
of	NULL
CD16	NULL
and	NULL
CD2	NULL
can	NULL
still	NULL
perform	NULL
spontaneous	NULL
cytotoxicity	NULL
.	NULL
``	NULL

At	NULL
least	NULL
two	NULL
pathways	NULL
of	NULL
NK-mediated	NULL
cytolysis	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

The	NULL
first	NULL
,	NULL
called	NULL
the	NULL
granule	NULL
exocytosis	NULL
is	NULL
mediated	NULL
by	NULL
releasing	NULL
mediators	NULL
stored	NULL
in	NULL
the	NULL
cytoplasmic	NULL
granules	NULL
such	NULL
as	NULL
the	NULL
pore-forming	NULL
perforin	NULL
,	NULL
granzymes	NULL
and	NULL
fragmentins	NULL
.	NULL

``	NULL
~	NULL
'	NULL
Received	NULL
12	NULL
June	NULL
1996	NULL
;	NULL
revised	NULL
20	NULL
November	NULL
1996	NULL
,	NULL
accepted	NULL
20	NULL
November	NULL
1996	NULL
.	NULL

Abbreviations	NULL
:	NULL
N-ALLN	NULL
,	NULL
N-acetyl-leu-leu-norleucinal	NULL
;	NULL
PDTC	NULL
,	NULL
Pyrrolidine	NULL
dithiocarbamate	NULL
;	NULL
ROI	NULL
,	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
;	NULL
TLCK	NULL
,	NULL
N-a-tosyl-L-lysine	NULL
chloromethyl	NULL
ketone	NULL
;	NULL
TPCK	NULL
,	NULL
N-x-tosyl-L-phenylalanine	NULL
chloromethyl	NULL
ketone	NULL
.	NULL

Correspondence	NULL
:	NULL
Dr	NULL
E.	NULL
Mufioz	NULL
,	NULL
Departamento	NULL
de	NULL
Fisiologia	NULL
e	NULL
Inmunologia	NULL
,	NULL
Facultad	NULL
de	NULL
Medicina	NULL
,	NULL
Avda	NULL
de	NULL
Menéndez	NULL
Pidal	NULL
s/n	NULL
,	NULL
Cordoba	NULL
14004	NULL
,	NULL
Spain	NULL
.	NULL

©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
455	NULL
The	NULL
second	NULL
pathway	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
Fas	NULL
ligand	NULL
protein	NULL
that	NULL
binds	NULL
Fas	NULL
molecules	NULL
present	NULL
at	NULL
the	NULL
surface	NULL
of	NULL
some	NULL
target	NULL
cells	NULL
,	NULL
thereby	NULL
triggering	NULL
their	NULL
apoptotic	NULL
death	NULL
.	NULL
``	NULL

Moreover	NULL
,	NULL
cytokines	NULL
produced	NULL
by	NULL
activated	NULL
NK	NULL
cells	NULL
may	NULL
contribute	NULL
to	NULL
its	NULL
cytolytic	NULL
function	NULL
.	NULL

*	NULL
Thus	NULL
,	NULL
NK-mediated	NULL
cytotoxicity	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
separated	NULL
signalling	NULL
transmission	NULL
pathways	NULL
.	NULL

Although	NULL
membrane	NULL
receptors	NULL
by	NULL
which	NULL
NK	NULL
cells	NULL
mediated	NULL
natural	NULL
cytotoxicity	NULL
have	NULL
to	NULL
be	NULL
entirely	NULL
defined	NULL
,	NULL
intracellular	NULL
changes	NULL
occurring	NULL
upon	NULL
ligation	NULL
with	NULL
NK-sensitive	NULL
target	NULL
cells	NULL
have	NULL
been	NULL
described	NULL
.	NULL

These	NULL
changes	NULL
include	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
phosphoinositide	NULL
hydrolysis	NULL
,	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
intracellular	NULL
calcium	NULL
mobilization	NULL
and	NULL
cytoplasm	NULL
acidification	NULL
.	NULL
'	NULL

''	NULL
~	NULL
``	NULL
These	NULL
proximal	NULL
intracellular	NULL
events	NULL
induced	NULL
by	NULL
cell	NULL
contact	NULL
have	NULL
to	NULL
be	NULL
followed	NULL
by	NULL
distal	NULL
events	NULL
that	NULL
in	NULL
turn	NULL
may	NULL
alter	NULL
the	NULL
activity	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
induce	NULL
a	NULL
certain	NULL
number	NULL
of	NULL
activation-associated	NULL
genes	NULL
that	NULL
in	NULL
the	NULL
case	NULL
of	NULL
NK	NULL
cells	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
both	NULL
cytolytic	NULL
response	NULL
and	NULL
cytokine	NULL
production	NULL
.	NULL

NF-xB	NULL
,	NULL
formerly	NULL
described	NULL
as	NULL
a	NULL
x	NULL
enhancer-binding	NULL
transcription	NULL
factor	NULL
constitutively	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
is	NULL
a	NULL
pleiotropic	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
many	NULL
genes	NULL
whose	NULL
products	NULL
participate	NULL
in	NULL
the	NULL
immune	NULL
or	NULL
inflammatory	NULL
response	NULL
.	NULL
``	NULL

''	NULL
It	NULL
is	NULL
made	NULL
of	NULL
hetero-	NULL
or	NULL
homodimeric	NULL
combinations	NULL
of	NULL
several	NULL
proteins	NULL
belonging	NULL
to	NULL
the	NULL
same	NULL
family	NULL
.	NULL

The	NULL
most	NULL
common	NULL
species	NULL
are	NULL
heterodimers	NULL
consisting	NULL
of	NULL
a	NULL
50000	NULL
MW	NULL
subunit	NULL
(	NULL
p50	NULL
)	NULL
and	NULL
either	NULL
a	NULL
65000	NULL
MW	NULL
protein	NULL
(	NULL
p65	NULL
or	NULL
RelA	NULL
)	NULL
or	NULL
the	NULL
456	NULL
M.	NULL
Valle-Blazquez	NULL
et	NULL
al	NULL
.	NULL

product	NULL
of	NULL
the	NULL
c-re/	NULL
oncogene	NULL
.	NULL

In	NULL
most	NULL
cell	NULL
types	NULL
,	NULL
NF-B	NULL
is	NULL
found	NULL
in	NULL
an	NULL
inactive	NULL
cytosolic	NULL
form	NULL
,	NULL
retained	NULL
by	NULL
association	NULL
with	NULL
its	NULL
inhibitor	NULL
,	NULL
IxB	NULL
.	NULL

``	NULL
``	NULL
``	NULL
°	NULL
Upon	NULL
cell	NULL
activation	NULL
by	NULL
phorbol	NULL
esters	NULL
,	NULL
mitogens	NULL
,	NULL
cytokines	NULL
,	NULL
ultraviolet	NULL
and	NULL
viral	NULL
proteins	NULL
,	NULL
IxB	NULL
undergoes	NULL
specific	NULL
modifications	NULL
and	NULL
is	NULL
subsequently	NULL
degraded	NULL
,	NULL
then	NULL
releasing	NULL
the	NULL
active	NULL
NF-xB	NULL
complex	NULL
to	NULL
the	NULL
Evidence	NULL
suggests	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROI	NULL
)	NULL
may	NULL
be	NULL
a	NULL
common	NULL
mediator	NULL
of	NULL
the	NULL
diverse	NULL
NF-	NULL
«	NULL
B-activating	NULL
signals	NULL
.	NULL

NF-xB	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
exogen-ous	NULL
hydrogen	NULL
peroxide	NULL
in	NULL
some	NULL
type	NULL
of	NULL
cells	NULL
'	NULL
``	NULL
and	NULL
also	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
factor	NULL
by	NULL
a	NULL
different	NULL
stimulus	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
antioxidant	NULL
thiols	NULL
or	NULL
iron	NULL
chelators	NULL
by	NULL
preventing	NULL
IxB	NULL
phosphorylation	NULL
,	NULL
``	NULL
``	NULL
a	NULL
process	NULL
that	NULL
it	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
the	NULL
IxBx	NULL
ubiquitination	NULL
and	NULL
degradation	NULL
by	NULL
the	NULL
26S	NULL
proteasome	NULL
.	NULL

``	NULL
!	NULL

We	NULL
show	NULL
here	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
AP-	NULL
in	NULL
NK	NULL
cells	NULL
activated	NULL
by	NULL
sensitive	NULL
target	NULL
cells	NULL
.	NULL

NF-xB	NULL
binding	NULL
activity	NULL
was	NULL
increased	NULL
in	NULL
both	NULL
peripheral	NULL
blood	NULL
NK	NULL
cells	NULL
stimulated	NULL
by	NULL
sensitive	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
NK	NULL
clones	NULL
stimulated	NULL
by	NULL
CIR	NULL
cells	NULL
.	NULL

This	NULL
binding	NULL
was	NULL
abolished	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
antioxidant	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
.	NULL

This	NULL
anti-oxidant	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
serine	NULL
protease	NULL
inhibitors	NULL
phenylalanine	NULL
chloromethyl	NULL
ketone	NULL
(	NULL
TPCK	NULL
)	NULL
and	NULL
chloromethyl	NULL
ketone	NULL
(	NULL
TLCK	NULL
)	NULL
were	NULL
able	NULL
to	NULL
inhibit	NULL
the	NULL
cytotoxic	NULL
activity	NULL
of	NULL
NK	NULL
cells	NULL
against	NULL
K562	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
incubation	NULL
of	NULL
NK	NULL
cells	NULL
with	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
N-acetyl-leu-leu-norleucinal	NULL
(	NULL
N-ALLN	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
its	NULL
cytotoxic	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
NK	NULL
cells	NULL
by	NULL
a	NULL
specific	NULL
target	NULL
may	NULL
result	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
ROI	NULL
that	NULL
mediate	NULL
both	NULL
granule	NULL
exocytosis	NULL
and	NULL
activation	NULL
of	NULL
some	NULL
transcription	NULL
factors	NULL
that	NULL
may	NULL
regulate	NULL
the	NULL
immune	NULL
response	NULL
of	NULL
NK	NULL
cells	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
and	NULL
monoclonal	NULL
antibodies	NULL
Complete	NULL
culture	NULL
medium	NULL
was	NULL
RPMI-1640	NULL
(	NULL
Bio-Whittaker	NULL
,	NULL
Belgium	NULL
)	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
1	NULL
mm	NULL
HEPES	NULL
,	NULL
antibiotics	NULL
(	NULL
Gibco	NULL
Ltd.	NULL
,	NULL
Paisley	NULL
,	NULL
UK	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
Bio-Whittaker	NULL
)	NULL
.	NULL

The	NULL
following	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
mAb	NULL
)	NULL
were	NULL
used	NULL
:	NULL
anti-leud4	NULL
(	NULL
anti-CD3	NULL
)	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
Becton-Dickinson	NULL
(	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
mAb	NULL
NKH-1	NULL
(	NULL
anti-CD56	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Coulter	NULL
(	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

The	NULL
mAb	NULL
3G8	NULL
(	NULL
anti-CD16	NULL
)	NULL
,	NULL
RMOS2	NULL
(	NULL
anti-CD14	NULL
)	NULL
,	NULL
and	NULL
J4.119	NULL
(	NULL
anti-CDI19	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Immunotech	NULL
(	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Antisera	NULL
used	NULL
to	NULL
detect	NULL
p50	NULL
(	NULL
#	NULL
350	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
#	NULL
1226	NULL
)	NULL
and	NULL
c-rel	NULL
were	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

The	NULL
(	NULL
y-*°P	NULL
)	NULL
ATP	NULL
(	NULL
6000	NULL
Ci/mmol	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
ICN	NULL
(	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

All	NULL
other	NULL
reagents	NULL
were	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Target	NULL
cell	NULL
lines	NULL
CIR	NULL
and	NULL
K562	NULL
were	NULL
used	NULL
as	NULL
target	NULL
cells	NULL
.	NULL

CIR	NULL
is	NULL
a	NULL
HLA-A	NULL
and	NULL
HLA-B	NULL
deficient	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B-cell	NULL
line	NULL
and	NULL
K562	NULL
is	NULL
an	NULL
erythroleukaemic	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
were	NULL
cultured	NULL
in	NULL
complete	NULL
medium	NULL
at	NULL
37°	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

NK-cell	NULL
purification	NULL
Polyclonal	NULL
NK	NULL
cells	NULL
from	NULL
healthy	NULL
donors	NULL
were	NULL
used	NULL
as	NULL
effector	NULL
cells	NULL
.	NULL

These	NULL
NK	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
venous	NULL
blood	NULL
from	NULL
healthy	NULL
donors	NULL
by	NULL
Ficoll-Hypaque	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Macrophages	NULL
were	NULL
depleted	NULL
by	NULL
plastic	NULL
adherence	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°	NULL
and	NULL
B	NULL
cells	NULL
were	NULL
removed	NULL
through	NULL
a	NULL
nylon	NULL
wool	NULL
column	NULL
.	NULL

Purified	NULL
non-adherent	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
anti-leud4	NULL
)	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
4°	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
cold	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
goat	NULL
anti-mouse	NULL
coated	NULL
magnetic	NULL
beads	NULL
(	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

After	NULL
immunomagnetic	NULL
separation	NULL
,	NULL
the	NULL
negative	NULL
selected	NULL
cells	NULL
consisted	NULL
of	NULL
80-90	NULL
%	NULL
CD56*	NULL
,	NULL
CD16*	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
cytometry	NULL
and	NULL
were	NULL
considered	NULL
the	NULL
peripheral	NULL
blood	NULL
NK	NULL
fraction	NULL
.	NULL

CD3	NULL
*	NULL
,	NULL
CDI19*	NULL
,	NULL
or	NULL
CD14	NULL
*	NULL
cells	NULL
were	NULL
not	NULL
detectable	NULL
(	NULL
<	NULL
5	NULL
%	NULL
)	NULL
.	NULL

Generation	NULL
of	NULL
NK-cell	NULL
clones	NULL
Peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
derived	NULL
from	NULL
a	NULL
typed	NULL
blood	NULL
donor	NULL
were	NULL
isolated	NULL
on	NULL
Ficoll-Hypaque	NULL
gradients	NULL
and	NULL
NK	NULL
cells	NULL
were	NULL
purified	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Viable	NULL
cells	NULL
CD3~	NULL
CD4~	NULL
CD8~	NULL
,	NULL
were	NULL
isolated	NULL
and	NULL
cloned	NULL
by	NULL
limiting	NULL
dilution	NULL
at	NULL
concentration	NULL
of	NULL
one	NULL
to	NULL
five	NULL
cells/well	NULL
in	NULL
96-well	NULL
U-bottom	NULL
plates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phytohaemagglutinin	NULL
(	NULL
PHA	NULL
;	NULL
01	NULL
%	NULL
v/v	NULL
;	NULL
Gibco	NULL
)	NULL
,	NULL
and	NULL
recombinant	NULL
interleukin-2	NULL
(	NULL
rIL-2	NULL
)	NULL
(	NULL
1000	NULL
U/ml	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
10	NULL
%	NULL
leucocyte-conditioned	NULL
medium	NULL
``	NULL
and	NULL
feeder	NULL
cells	NULL
.	NULL

These	NULL
consisted	NULL
of	NULL
10°	NULL
irradiated	NULL
(	NULL
6000	NULL
rads	NULL
)	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
well	NULL
.	NULL

After	NULL
10	NULL
days	NULL
,	NULL
proliferating	NULL
cultures	NULL
were	NULL
transferred	NULL
to	NULL
96-well	NULL
flat-bottomed	NULL
plates	NULL
and	NULL
further	NULL
expanded	NULL
in	NULL
complete	NULL
medium	NULL
.	NULL

NK-cell	NULL
clones	NULL
were	NULL
restimulated	NULL
with	NULL
feeder	NULL
cells	NULL
every	NULL
3-4	NULL
weeks	NULL
.	NULL

Two	NULL
clones	NULL
(	NULL
104	NULL
and	NULL
123	NULL
)	NULL
used	NULL
in	NULL
this	NULL
study	NULL
showed	NULL
cytotoxic	NULL
activity	NULL
against	NULL
the	NULL
CIR	NULL
target	NULL
cells	NULL
and	NULL
display	NULL
a	NULL
CD3~/CD56*/CD16+*	NULL
phenotype	NULL
.	NULL

Cytotoxicity	NULL
assays	NULL
K562	NULL
target	NULL
cells	NULL
were	NULL
combined	NULL
with	NULL
purified	NULL
polyclonal	NULL
NK	NULL
cells	NULL
at	NULL
the	NULL
indicated	NULL
effector	NULL
:	NULL
target	NULL
ratios	NULL
using	NULL
5	NULL
x	NULL
10°	NULL
targets	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
200	NULL
ul	NULL
per	NULL
V-bottom	NULL
microtitre	NULL
plate	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
centrifuged	NULL
at	NULL
500	NULL
g	NULL
for	NULL
2	NULL
min	NULL
,	NULL
then	NULL
incubated	NULL
for	NULL
4	NULL
hr	NULL
at	NULL
37°	NULL
.	NULL

Plates	NULL
were	NULL
then	NULL
centrifuged	NULL
at	NULL
1000	NULL
r.p.m	NULL
.	NULL

for	NULL
5	NULL
min	NULL
,	NULL
50	NULL
ul	NULL
aliquots	NULL
were	NULL
removed	NULL
and	NULL
tested	NULL
for	NULL
lactate	NULL
dehydrogenase	NULL
(	NULL
LDH	NULL
)	NULL
activity	NULL
using	NULL
the	NULL
CytoTox	NULL
96	NULL
kit	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Percentages	NULL
of	NULL
specific	NULL
cytotoxicity	NULL
were	NULL
calculated	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Preparation	NULL
of	NULL
protein	NULL
extracts	NULL
Polyclonal	NULL
NK	NULL
cells	NULL
or	NULL
NK	NULL
clones	NULL
(	NULL
25x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
x	NULL
10°	NULL
of	NULL
the	NULL
indicated	NULL
target	NULL
cells	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
medium	NULL
in	NULL
V-microtitre	NULL
plates	NULL
.	NULL

As	NULL
positive	NULL
control	NULL
effector	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
;	NULL
50	NULL
ng/ml	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
target	NULL
cells	NULL
.	NULL

Plates	NULL
were	NULL
centrifuged	NULL
and	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
37°	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

After	NULL
that	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
recovered	NULL
and	NULL
centrifuged	NULL
in	NULL
an	NULL
Eppendorf	NULL
tube	NULL
,	NULL
washed	NULL
with	NULL
cold	NULL
PBS	NULL
and	NULL
centrifuged	NULL
again	NULL
.	NULL

Sedimented	NULL
cells	NULL
were	NULL
gently	NULL
resuspended	NULL
and	NULL
disrupted	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
pH	NULL
7-9	NULL
,	NULL
0-35	NULL
m	NULL
NaCl	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
1mm	NULL
MgCl	NULL
,	NULL
,	NULL
0-5	NULL
mm	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
0-5	NULL
mm	NULL
ethylene	NULL
diaminetetraacetic	NULL
acid	NULL
(	NULL
EDTA	NULL
)	NULL
,	NULL
0-1	NULL
mM	NULL
ethylene	NULL
glycol-bis	NULL
(	NULL
$	NULL
-aminoethyl	NULL
)	NULL
ether	NULL
(	NULL
EGTA	NULL
)	NULL
,	NULL
protease	NULL
inhibitor	NULL
(	NULL
1	NULL
ug/ml	NULL
each	NULL
of	NULL
apronitin	NULL
,	NULL
leupeptin	NULL
and	NULL
pepstatine	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylIsulphonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
,	NULL
and	NULL
02	NULL
%	NULL
nonidet	NULL
P-40	NULL
(	NULL
NP-40	NULL
)	NULL
.	NULL

After	NULL
lysis	NULL
,	NULL
samples	NULL
were	NULL
centrifugated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
10	NULL
000	NULL
g	NULL
,	NULL
supernatants	NULL
were	NULL
carefully	NULL
recovered	NULL
and	NULL
placed	NULL
in	NULL
new	NULL
Eppendorf	NULL
tubes	NULL
.	NULL

©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
90	NULL
,	NULL
455-460	NULL
Cellular	NULL
redox	NULL
status	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
457	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Double-stranded	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
xB	NULL
binding	NULL
site	NULL
located	NULL
in	NULL
the	NULL
enhancer	NULL
region	NULL
of	NULL
the	NULL
H-2°	NULL
promoter	NULL
(	NULL
KBF	NULL
)	NULL
or	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
located	NULL
in	NULL
the	NULL
metallothionine	NULL
promoter	NULL
were	NULL
used	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
contained	NULL
10	NULL
ug	NULL
of	NULL
proteins	NULL
,	NULL
1	NULL
ug	NULL
poly	NULL
20	NULL
mm	NULL
HEPES	NULL
pH	NULL
7	NULL
,	NULL
50	NULL
mm	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
0-01	NULL
%	NULL
NP-40	NULL
,	NULL
100	NULL
ug/ml	NULL
BSA	NULL
,	NULL
4	NULL
%	NULL
Ficoll	NULL
,	NULL
and	NULL
100000	NULL
c.p.m	NULL
.	NULL

of	NULL
end-labelled	NULL
DNA	NULL
fragments	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
0:5	NULL
ul	NULL
of	NULL
rabbit	NULL
anti-p50	NULL
,	NULL
anti-RelA	NULL
,	NULL
anti	NULL
c-rel	NULL
,	NULL
or	NULL
preimmune	NULL
serum	NULL
was	NULL
added	NULL
to	NULL
the	NULL
standard	NULL
reaction	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radiolabelled	NULL
probe	NULL
.	NULL

For	NULL
cold	NULL
competition	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
the	NULL
double-stranded	NULL
oligonucleotide	NULL
competitor	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

After	NULL
30	NULL
min	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
mixture	NULL
was	NULL
electrophoresed	NULL
through	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
non-denaturing	NULL
conditions	NULL
and	NULL
was	NULL
subsequently	NULL
dried	NULL
and	NULL
exposed	NULL
at	NULL
-80°	NULL
to	NULL
XAR	NULL
film	NULL
.	NULL

RESULTS	NULL
Induction	NULL
of	NULL
NF-xB-binding	NULL
activity	NULL
in	NULL
NK	NULL
cells	NULL
stimulated	NULL
by	NULL
its	NULL
interaction	NULL
with	NULL
target	NULL
cells	NULL
Treatment	NULL
of	NULL
purified	NULL
peripheral	NULL
blood	NULL
NK	NULL
cells	NULL
with	NULL
K562	NULL
cells	NULL
rapidly	NULL
activates	NULL
the	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
using	NULL
a	NULL
*°P-labelled	NULL
KBF	NULL
oligonucleotide	NULL
.	NULL

The	NULL
binding	NULL
was	NULL
already	NULL
detected	NULL
after	NULL
15	NULL
min	NULL
of	NULL
K562	NULL
activation	NULL
and	NULL
was	NULL
maintained	NULL
up	NULL
to	NULL
90	NULL
min	NULL
after	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
complex	NULL
migrated	NULL
to	NULL
an	NULL
extent	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
complex	NULL
found	NULL
in	NULL
PMA-stimulated	NULL
NK	NULL
cells	NULL
The	NULL
specificity	NULL
of	NULL
such	NULL
Competitor	NULL
K562	NULL
(	NULL
min	NULL
)	NULL
[	NULL
eal	NULL
<	NULL
<	NULL
|	NULL
5	NULL
0	NULL
15	NULL
so	NULL
60	NULL
90	NULL
Z	NULL
A	NULL
«	NULL
wb	NULL
~~	NULL
|	NULL
0	NULL
bh	NULL
AP	NULL
-1	NULL
SP	NULL
-	NULL
1	NULL
«	NULL
€	NULL
NF-xB	NULL
&	NULL
.	NULL

«	NULL
dill	NULL
bebo	NULL
Figure	NULL
1	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

Purified	NULL
peripheral	NULL
blood	NULL
NK	NULL
cells	NULL
(	NULL
2:5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
k562	NULL
cells	NULL
(	NULL
5x	NULL
10°	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
or	NULL
activated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Total	NULL
proteins	NULL
were	NULL
extracted	NULL
and	NULL
subjected	NULL
(	NULL
10	NULL
ug	NULL
in	NULL
each	NULL
lane	NULL
)	NULL
to	NULL
EMSA	NULL
using	NULL
an	NULL
end-labeled	NULL
KBF	NULL
probe	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

Proteins	NULL
from	NULL
the	NULL
60	NULL
min	NULL
stimulation	NULL
were	NULL
subjected	NULL
to	NULL
cold	NULL
competition	NULL
by	NULL
using	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabelled	NULL
IgxB	NULL
,	NULL
AP-1	NULL
or	NULL
SP-l	NULL
double-stranded	NULL
oligonucleotides	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
90	NULL
,	NULL
455-460	NULL
binding	NULL
was	NULL
demonstrated	NULL
by	NULL
cold	NULL
competition	NULL
experiments	NULL
using	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
the	NULL
related	NULL
IgxB	NULL
,	NULL
or	NULL
unrelated	NULL
AP-1	NULL
and	NULL
SP-1	NULL
oligonucleotides	NULL
.	NULL

Figure	NULL
1	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
shows	NULL
that	NULL
IgxB	NULL
but	NULL
not	NULL
AP-1	NULL
or	NULL
SP-1	NULL
oligonucleotides	NULL
competed	NULL
for	NULL
the	NULL
NF-xB-binding	NULL
activity	NULL
with	NULL
the	NULL
end-labelled	NULL
KBF	NULL
probe	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
supershift	NULL
experiments	NULL
demonstrated	NULL
that	NULL
this	NULL
binding	NULL
protein	NULL
was	NULL
by	NULL
p50/RelIA	NULL
heterodimer	NULL
of	NULL
the	NULL
NF-xB	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
ascertain	NULL
that	NULL
NF-	NULL
«	NULL
xB	NULL
was	NULL
activated	NULL
in	NULL
NK	NULL
-cell	NULL
clones	NULL
,	NULL
104	NULL
and	NULL
123	NULL
clones	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
or	NULL
incubated	NULL
with	NULL
the	NULL
sensitive	NULL
CIR	NULL
target	NULL
cells	NULL
,	NULL
and	NULL
both	NULL
NF-	NULL
«	NULL
xB	NULL
and	NULL
AP-1	NULL
binding	NULL
detected	NULL
by	NULL
EMSA	NULL
.	NULL

Figure	NULL
2	NULL
shows	NULL
that	NULL
NF-xB	NULL
as	NULL
well	NULL
as	NULL
AP-1	NULL
were	NULL
activated	NULL
in	NULL
both	NULL
NK	NULL
cell	NULL
clones	NULL
.	NULL

Proteins	NULL
extracted	NULL
from	NULL
5	NULL
x	NULL
10°	NULL
C1R	NULL
cells	NULL
did	NULL
not	NULL
show	NULL
detectable	NULL
NF-xB	NULL
or	NULL
activities	NULL
,	NULL
ruling	NULL
out	NULL
that	NULL
the	NULL
binding	NULL
activities	NULL
detected	NULL
were	NULL
from	NULL
target	NULL
cells	NULL
.	NULL

The	NULL
lower	NULL
band	NULL
that	NULL
appears	NULL
in	NULL
proteins	NULL
extracted	NULL
from	NULL
CIR	NULL
cells	NULL
(	NULL
lane	NULL
14	NULL
)	NULL
was	NULL
not	NULL
specific	NULL
for	NULL
AP-1	NULL
since	NULL
an	NULL
excess	NULL
of	NULL
cold	NULL
AP-1	NULL
oligonucleotide	NULL
did	NULL
not	NULL
outcompete	NULL
it	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
xB/Rel	NULL
family	NULL
involved	NULL
in	NULL
the	NULL
NF-xB-binding	NULL
activity	NULL
observed	NULL
in	NULL
activated	NULL
NK-cell	NULL
clones	NULL
,	NULL
we	NULL
performed	NULL
supershift	NULL
retardation	NULL
assays	NULL
with	NULL
a	NULL
specific	NULL
antisera	NULL
.	NULL

NF-xB-binding	NULL
activities	NULL
detected	NULL
in	NULL
both	NULL
cell	NULL
clones	NULL
were	NULL
composed	NULL
of	NULL
p50/p65	NULL
(	NULL
p50/ReIA	NULL
)	NULL
and	NULL
p50/c-rel	NULL
heterodimers	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Preimmune	NULL
antisera	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
binding	NULL
of	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
PDTC	NULL
on	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
binding	NULL
activities	NULL
in	NULL
NK-stimulated	NULL
cells	NULL
The	NULL
differential	NULL
regulation	NULL
of	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
in	NULL
response	NULL
to	NULL
an	NULL
oxidative	NULL
stress	NULL
has	NULL
been	NULL
previously	NULL
g	NULL
t	NULL
0.9	NULL
8	NULL
``	NULL
v	NULL
of	NULL
}	NULL
[	NULL
--	NULL
A	NULL
O1	NULL
[	NULL
--	NULL
A	NULL
1	NULL
1	NULL
2	NULL
8	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
13	NULL
14	NULL
7	NULL
p-	NULL
-	NULL
ss	NULL
``	NULL
.	NULL

i	NULL
%	NULL
«	NULL
€	NULL
AP-1	NULL
‘	NULL
g	NULL
#	NULL
€	NULL
NF-	NULL
«	NULL
B	NULL
|	NULL
cas	NULL
|	NULL
®	NULL
|	NULL
M	NULL
sinn	NULL
mac	NULL
.	NULL

lke	NULL
B	NULL
al	NULL
ais	NULL
.	NULL

|	NULL
..	NULL
as	NULL
Figure	NULL
2	NULL
.	NULL

Activation	NULL
of	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
DNA	NULL
binding	NULL
in	NULL
stimulated	NULL
NK	NULL
clones	NULL
.	NULL

NK	NULL
clones	NULL
104	NULL
and	NULL
123	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
either	NULL
incubated	NULL
with	NULL
5x	NULL
10°	NULL
CIR	NULL
target	NULL
cells	NULL
for	NULL
60	NULL
min	NULL
or	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
binding	NULL
activity	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
7	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
14	NULL
)	NULL
sites	NULL
were	NULL
detected	NULL
by	NULL
EMSA	NULL
.	NULL

Lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
8	NULL
and	NULL
11	NULL
(	NULL
unstimulated	NULL
clones	NULL
)	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
9	NULL
(	NULL
PMA-stimulated	NULL
clones	NULL
)	NULL
;	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
10	NULL
and	NULL
12	NULL
(	NULL
C1R-stimulated	NULL
clones	NULL
)	NULL
;	NULL
lanes	NULL
6	NULL
and	NULL
13	NULL
,	NULL
and	NULL
7	NULL
and	NULL
14	NULL
represent	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
proteins	NULL
obtained	NULL
from	NULL
5	NULL
x	NULL
10°	NULL
unstimulated	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
CIR	NULL
cells	NULL
respectively	NULL
.	NULL

458	NULL
M.	NULL
Valle-Blazquez	NULL
et	NULL
al	NULL
.	NULL

104	NULL
128	NULL
Antibody	NULL
g	NULL
8	NULL
®	NULL
a	NULL
€	NULL
E	NULL
a	NULL
o	NULL
6	NULL
a	NULL
2	NULL
=o	NULL
[	NULL
~-	NULL
ae	NULL
~	NULL
tit	NULL
tus	NULL
-	NULL
di	NULL
fed	NULL
wut	NULL
p50/relA	NULL
#	NULL
``	NULL
ag	NULL
``	NULL
s	NULL
iss	NULL
~	NULL
p50/c-re	NULL
Figure	NULL
3	NULL
.	NULL

Identification	NULL
of	NULL
NF-xB	NULL
complexes	NULL
in	NULL
NK-cell	NULL
clones	NULL
;	NULL
104	NULL
and	NULL
123	NULL
NK-cell	NULL
clones	NULL
were	NULL
incubated	NULL
with	NULL
CIR	NULL
target	NULL
cells	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Proteins	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
specific	NULL
NF-xB	NULL
antisera	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
the	NULL
NF-xB	NULL
complexes	NULL
identified	NULL
by	NULL
EMSA	NULL
.	NULL

Antisera	NULL
anti-p50	NULL
and	NULL
anti-p65	NULL
induce	NULL
a	NULL
supershift	NULL
of	NULL
the	NULL
binding	NULL
complexes	NULL
,	NULL
and	NULL
c-re/	NULL
antiserum	NULL
prevent	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
c-re/	NULL
complexes	NULL
.	NULL

described	NULL
in	NULL
other	NULL
cells	NULL
.	NULL

``	NULL
``	NULL
>	NULL
``	NULL
Thus	NULL
,	NULL
to	NULL
study	NULL
whether	NULL
or	NULL
not	NULL
the	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
activities	NULL
in	NULL
stimulated	NULL
NK	NULL
cells	NULL
were	NULL
affected	NULL
by	NULL
the	NULL
intracellular	NULL
redox	NULL
system	NULL
,	NULL
we	NULL
preincubated	NULL
the	NULL
NK	NULL
cells	NULL
with	NULL
the	NULL
radical	NULL
scavenger	NULL
PDTC	NULL
for	NULL
1	NULL
hr	NULL
prior	NULL
to	NULL
the	NULL
stimulation	NULL
with	NULL
PMA	NULL
or	NULL
with	NULL
K562	NULL
cells	NULL
.	NULL

We	NULL
show	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
that	NULL
100	NULL
um	NULL
of	NULL
PDTC	NULL
blocked	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
nuclear	NULL
NF-	NULL
NF-xB	NULL
AP-1	NULL
|	NULL
#	NULL
a.	NULL
Tik	NULL
dik	NULL
a	NULL
nts	NULL
links	NULL
e	NULL
n	NULL
Figure	NULL
4	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PDTC	NULL
on	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
binding	NULL
in	NULL
activated	NULL
NK	NULL
cells	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
8	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
16	NULL
)	NULL
binding	NULL
activities	NULL
were	NULL
detected	NULL
in	NULL
protein	NULL
extracts	NULL
of	NULL
purified	NULL
peripheral	NULL
NK	NULL
cells	NULL
stimulated	NULL
as	NULL
follow	NULL
:	NULL
lanes	NULL
1	NULL
and	NULL
9	NULL
,	NULL
unstimulated	NULL
cells	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
10	NULL
,	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/m1	NULL
)	NULL
for	NULL
30	NULL
min	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
11	NULL
,	NULL
stimulated	NULL
with	NULL
K562	NULL
cells	NULL
for	NULL
60	NULL
min	NULL
at	NULL
the	NULL
same	NULL
ratio	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
12	NULL
,	NULL
unstimulated	NULL
NK	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PDTC	NULL
(	NULL
100	NULL
um	NULL
)	NULL
;	NULL
lanes	NULL
5	NULL
and	NULL
13	NULL
,	NULL
same	NULL
as	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PDTC	NULL
;	NULL
lanes	NULL
6	NULL
and	NULL
14	NULL
,	NULL
same	NULL
as	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PDTC	NULL
.	NULL

Lanes	NULL
7	NULL
and	NULL
15	NULL
and	NULL
8	NULL
and	NULL
16	NULL
correspond	NULL
to	NULL
K562	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
treated	NULL
or	NULL
no	NULL
with	NULL
PDTC	NULL
.	NULL

xB	NULL
induced	NULL
in	NULL
NK	NULL
cells	NULL
by	NULL
both	NULL
PMA	NULL
and	NULL
K562	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
AP-1-binding	NULL
activity	NULL
was	NULL
superinduced	NULL
by	NULL
PDTC	NULL
in	NULL
K562-stimulated	NULL
NK	NULL
cells	NULL
but	NULL
was	NULL
inhibited	NULL
in	NULL
PMA-stimulated	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
PMA	NULL
and	NULL
K562	NULL
mediate	NULL
different	NULL
signalling	NULL
pathways	NULL
leading	NULL
to	NULL
the	NULL
AP-1	NULL
activation	NULL
.	NULL

Effect	NULL
of	NULL
PDTC	NULL
on	NULL
NK-cell	NULL
cytotoxic	NULL
activity	NULL
In	NULL
order	NULL
to	NULL
analyse	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
antioxidant	NULL
PDTC	NULL
in	NULL
the	NULL
cytotoxic	NULL
activity	NULL
of	NULL
NK	NULL
cells	NULL
,	NULL
we	NULL
treated	NULL
purified	NULL
peripheral	NULL
blood	NULL
NK	NULL
cells	NULL
with	NULL
PDTC	NULL
for	NULL
1	NULL
hr	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
target	NULL
cells	NULL
at	NULL
different	NULL
effector	NULL
:	NULL
target	NULL
ratios	NULL
.	NULL

The	NULL
cytotoxic	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
release	NULL
of	NULL
LDH	NULL
from	NULL
target	NULL
cells	NULL
as	NULL
described	NULL
above	NULL
.	NULL

PDTC	NULL
was	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
the	NULL
spontaneous	NULL
cytotoxicity	NULL
mediated	NULL
by	NULL
polyclonal	NULL
NK	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

PDTC	NULL
alone	NULL
was	NULL
not	NULL
toxic	NULL
for	NULL
the	NULL
target	NULL
cells	NULL
because	NULL
K562	NULL
cells	NULL
treated	NULL
with	NULL
this	NULL
antioxidant	NULL
showed	NULL
normal	NULL
spontaneous	NULL
LDH	NULL
release	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
untreated	NULL
control	NULL
cells	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
NK	NULL
activity	NULL
by	NULL
PDTC	NULL
was	NULL
concentration	NULL
dependent	NULL
,	NULL
and	NULL
while	NULL
100	NULL
um	NULL
PDTC	NULL
resulted	NULL
in	NULL
100	NULL
%	NULL
inhibition	NULL
,	NULL
50	NULL
and	NULL
25	NULL
uM	NULL
mediated	NULL
72	NULL
%	NULL
and	NULL
40	NULL
%	NULL
of	NULL
inhibition	NULL
respectively	NULL
.	NULL

Moreover	NULL
,	NULL
pretreatment	NULL
of	NULL
purified	NULL
NK	NULL
cells	NULL
with	NULL
N-acetyl-L-cysteine	NULL
,	NULL
a	NULL
cysteine	NULL
derivative	NULL
that	NULL
can	NULL
raise	NULL
intracellular	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
levels	NULL
and	NULL
thereby	NULL
protect	NULL
cells	NULL
from	NULL
the	NULL
effects	NULL
of	NULL
ROI	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
complete	NULL
inhibition	NULL
of	NULL
NK	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
serine	NULL
proteases	NULL
and	NULL
proteasoma	NULL
inhibitors	NULL
on	NULL
NK-cell	NULL
cytotoxic	NULL
activity	NULL
It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
antioxidants	NULL
,	NULL
serine	NULL
protease	NULL
inhibitors	NULL
such	NULL
as	NULL
chloromethyl	NULL
ketones	NULL
and	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
,	NULL
N-ALLN	NULL
,	NULL
are	NULL
potent	NULL
inhibitors	NULL
of	NULL
NF-xB	NULL
activation	NULL
by	NULL
blocking	NULL
the	NULL
degradation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
xB	NULL
inhibitor	NULL
.	NULL

*	NULL
``	NULL
``	NULL
``	NULL
To	NULL
study	NULL
whether	NULL
these	NULL
compounds	NULL
were	NULL
able	NULL
to	NULL
inhibit	NULL
NK	NULL
cell-mediated	NULL
cytotoxicity	NULL
,	NULL
we	NULL
treated	NULL
effector	NULL
cells	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
either	NULL
TPCK	NULL
,	NULL
804	NULL
-	NULL
BIM	NULL
Control	NULL
CI	NULL
PDTC	NULL
s0	NULL
€	NULL
2	NULL
@	NULL
>	NULL
8	NULL
-	NULL
«	NULL
04	NULL
$	NULL
20	NULL
{	NULL
I	NULL
1:1	NULL
10:1	NULL
25:1	NULL
50:1	NULL
Ratio	NULL
(	NULL
E	NULL
:	NULL
T	NULL
)	NULL
Figure	NULL
5	NULL
.	NULL

Inhibition	NULL
of	NULL
NK	NULL
cytolytic	NULL
activity	NULL
by	NULL
PDTC	NULL
.	NULL

Purified	NULL
NK	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
PDTC	NULL
(	NULL
100	NULL
um	NULL
)	NULL
for	NULL
60	NULL
min	NULL
,	NULL
and	NULL
then	NULL
tested	NULL
for	NULL
cytolytic	NULL
activity	NULL
against	NULL
K562	NULL
cells	NULL
using	NULL
a	NULL
LDH	NULL
detection	NULL
system	NULL
.	NULL

One	NULL
representative	NULL
out	NULL
of	NULL
the	NULL
three	NULL
independent	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
90	NULL
,	NULL
455-460	NULL
Cellular	NULL
redox	NULL
status	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
459	NULL
N	NULL
TLCK	NULL
so	NULL
|-	NULL
A	NULL
TPCK	NULL
©	NULL
N-ALLN	NULL
Specific	NULL
lysis	NULL
(	NULL
%	NULL
)	NULL
p	NULL
o	NULL
O	NULL
o	NULL
T	NULL
T	NULL
No	NULL
O	NULL
I	NULL
0	NULL
10	NULL
_	NULL
25	NULL
-	NULL
50	NULL
-	NULL
100	NULL
(	NULL
um	NULL
)	NULL
Figure	NULL
6	NULL
.	NULL

Effects	NULL
of	NULL
chloromethyl	NULL
ketones	NULL
and	NULL
N-ALLN	NULL
on	NULL
NK	NULL
activity	NULL
.	NULL

The	NULL
cytolytic	NULL
activity	NULL
of	NULL
purified	NULL
NK	NULL
cells	NULL
against	NULL
K562	NULL
cells	NULL
was	NULL
studied	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
TPCK	NULL
,	NULL
TLCK	NULL
or	NULL
N-ALLN	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
.	NULL

One	NULL
representative	NULL
out	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

TLCK	NULL
,	NULL
or	NULL
N-ALLN	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
incubation	NULL
with	NULL
the	NULL
K562	NULL
target	NULL
cells	NULL
at	NULL
the	NULL
ratio	NULL
25	NULL
:	NULL
1	NULL
(	NULL
E	NULL
:	NULL
T	NULL
)	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

6	NULL
it	NULL
is	NULL
shown	NULL
that	NULL
both	NULL
serine	NULL
protease	NULL
inhibitors	NULL
,	NULL
TPCK	NULL
and	NULL
TLCK	NULL
,	NULL
were	NULL
able	NULL
to	NULL
inhibit	NULL
NK	NULL
cytolytic	NULL
activity	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
N-ALLN	NULL
at	NULL
concentrations	NULL
ranging	NULL
from	NULL
25	NULL
to	NULL
100	NULL
um	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
lysis	NULL
of	NULL
K562	NULL
cells	NULL
mediated	NULL
by	NULL
NK	NULL
effector	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
Eukaryotic	NULL
cells	NULL
continuously	NULL
produce	NULL
ROI	NULL
as	NULL
side	NULL
products	NULL
of	NULL
the	NULL
redox	NULL
reaction	NULL
.	NULL

The	NULL
generation	NULL
of	NULL
ROI	NULL
is	NULL
mostly	NULL
governed	NULL
by	NULL
mitochondria	NULL
and	NULL
the	NULL
ROI	NULL
comprise	NULL
hydrogen	NULL
peroxide	NULL
,	NULL
hydroxyl	NULL
radicals	NULL
and	NULL
superoxide	NULL
anions	NULL
.	NULL

All	NULL
of	NULL
them	NULL
are	NULL
essential	NULL
compounds	NULL
of	NULL
the	NULL
oxidative	NULL
metabolism	NULL
.	NULL
``	NULL

''	NULL
Under	NULL
physiological	NULL
conditions	NULL
the	NULL
intracellular	NULL
levels	NULL
of	NULL
ROI	NULL
are	NULL
finely	NULL
tuned	NULL
by	NULL
cellular	NULL
enzymes	NULL
with	NULL
radical	NULL
scavenging	NULL
activities	NULL
.	NULL
``	NULL

''	NULL
We	NULL
have	NULL
shown	NULL
in	NULL
this	NULL
report	NULL
that	NULL
the	NULL
cytotoxic	NULL
activity	NULL
of	NULL
NK	NULL
cells	NULL
is	NULL
completely	NULL
abrogated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
thiol	NULL
scavenger	NULL
PDTC	NULL
and	NULL
by	NULL
serine	NULL
protease	NULL
inhibitors	NULL
.	NULL

Such	NULL
inhibition	NULL
can	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
compounds	NULL
to	NULL
inhibit	NULL
NF-xB	NULL
activation	NULL
since	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
,	NULL
N-ALL-N	NULL
,	NULL
which	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
cytotoxic	NULL
activity	NULL
of	NULL
NK	NULL
cells	NULL
was	NULL
able	NULL
to	NULL
inhibit	NULL
the	NULL
NF-	NULL
«	NULL
xB	NULL
binding	NULL
to	NULL
DNA	NULL
in	NULL
NK	NULL
cells	NULL
stimulated	NULL
by	NULL
its	NULL
specific	NULL
target	NULL
(	NULL
M.	NULL
V.	NULL
Blazquez	NULL
and	NULL
E.	NULL
Mufioz	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
results	NULL
we	NULL
propose	NULL
that	NULL
activation	NULL
of	NULL
NK	NULL
cells	NULL
by	NULL
cell	NULL
contact	NULL
with	NULL
its	NULL
specific	NULL
targets	NULL
,	NULL
would	NULL
result	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
ROI	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
may	NULL
regulate	NULL
two	NULL
sequential	NULL
processes	NULL
.	NULL

First	NULL
,	NULL
ROI	NULL
can	NULL
activate	NULL
a	NULL
cascade	NULL
of	NULL
kinases	NULL
and/or	NULL
proteases	NULL
leading	NULL
to	NULL
the	NULL
releasing	NULL
of	NULL
pore-performing	NULL
granules	NULL
by	NULL
post-transcriptional	NULL
mechanisms	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
chloromethyl	NULL
ketones	NULL
may	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
granzymes	NULL
rather	NULL
than	NULL
their	NULL
release	NULL
from	NULL
cytoplasmic	NULL
granules	NULL
.	NULL

Secondly	NULL
,	NULL
this	NULL
cascade	NULL
of	NULL
signalling	NULL
may	NULL
result	NULL
also	NULL
in	NULL
the	NULL
ubiquitination	NULL
and	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
&	NULL
,	NULL
``	NULL
*	NULL
a	NULL
previous	NULL
step	NULL
required	NULL
for	NULL
degradation	NULL
of	NULL
this	NULL
protein	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-xB	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
ROI	NULL
generated	NULL
by	NULL
cell	NULL
contact	NULL
may	NULL
influence	NULL
the	NULL
binding	NULL
of	NULL
AP-1	NULL
.	NULL

It	NULL
has	NULL
©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
90	NULL
,	NULL
455-460	NULL
been	NULL
proposed	NULL
that	NULL
activation	NULL
of	NULL
AP-l	NULL
is	NULL
governed	NULL
by	NULL
a	NULL
complex	NULL
pathway	NULL
that	NULL
involves	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
mechanisms	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
NK	NULL
-cell	NULL
contact	NULL
with	NULL
sensitive	NULL
target	NULL
cells	NULL
results	NULL
in	NULL
c-Jun	NULL
phosphorylation	NULL
and	NULL
this	NULL
conformational	NULL
change	NULL
of	NULL
pre-existing	NULL
AP-1	NULL
complexes	NULL
,	NULL
allows	NULL
the	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

As	NULL
previously	NULL
described	NULL
,	NULL
the	NULL
action	NULL
of	NULL
antioxidants	NULL
on	NULL
AP-1	NULL
binding	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
transcriptional	NULL
mechanisms	NULL
that	NULL
induce	NULL
c-fos	NULL
and	NULL
c-fun	NULL
gene	NULL
transcription	NULL
.	NULL

``	NULL
*	NULL
It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
lytic	NULL
pathway	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
proliferative	NULL
pathway	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
but	NULL
the	NULL
generation	NULL
of	NULL
ROI	NULL
may	NULL
be	NULL
a	NULL
very	NULL
early	NULL
step	NULL
common	NULL
to	NULL
those	NULL
pathways	NULL
.	NULL

This	NULL
concept	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
previous	NULL
report	NULL
indicating	NULL
that	NULL
thiol	NULL
compounds	NULL
,	NULL
such	NULL
as	NULL
2-mercaptoethanol	NULL
(	NULL
2-ME	NULL
)	NULL
or	NULL
reduced	NULL
glutathione	NULL
,	NULL
potentiates	NULL
the	NULL
ability	NULL
of	NULL
IL-2	NULL
to	NULL
induce	NULL
both	NULL
the	NULL
cytotoxic	NULL
activity	NULL
and	NULL
the	NULL
proliferation	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
Moreover	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
NK	NULL
cytotoxicity	NULL
by	NULL
dithiocarbamates	NULL
may	NULL
be	NULL
overruled	NULL
by	NULL
sulphydryl	NULL
compounds	NULL
which	NULL
abolish	NULL
the	NULL
capacity	NULL
of	NULL
this	NULL
compound	NULL
as	NULL
a	NULL
free	NULL
radical	NULL
scavenger	NULL
.	NULL
``	NULL

Recent	NULL
evidence	NULL
has	NULL
demonstrated	NULL
that	NULL
cytotoxicity	NULL
by	NULL
NK	NULL
cells	NULL
is	NULL
controlled	NULL
by	NULL
activating	NULL
and	NULL
inhibitory	NULL
receptors	NULL
.	NULL

``	NULL
``	NULL
°	NULL
``	NULL
``	NULL
Among	NULL
those	NULL
that	NULL
activate	NULL
,	NULL
the	NULL
best	NULL
characterized	NULL
is	NULL
the	NULL
rat	NULL
NKR-P1	NULL
,	NULL
a	NULL
type	NULL
II	NULL
integral	NULL
protein	NULL
that	NULL
after	NULL
ligation	NULL
with	NULL
specific	NULL
mAb	NULL
,	NULL
activates	NULL
phosphoinositide	NULL
turnover	NULL
and	NULL
increases	NULL
the	NULL
levels	NULL
of	NULL
intracellular	NULL
calcium	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
signalling	NULL
pathways	NULL
activates	NULL
by	NULL
NKR-PI	NULL
receptor	NULL
and	NULL
other	NULL
NK	NULL
antigens	NULL
depend	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
CD45	NULL
,	NULL
``	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
that	NULL
participate	NULL
in	NULL
the	NULL
cytolytic	NULL
response	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
role	NULL
of	NULL
tyrosine	NULL
phosphatases	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
activation	NULL
has	NULL
been	NULL
previously	NULL
suggested	NULL
.	NULL

``	NULL
``	NULL
``	NULL
°	NULL
Much	NULL
less	NULL
is	NULL
known	NULL
about	NULL
the	NULL
signalling	NULL
pathways	NULL
mediated	NULL
by	NULL
inhibitory	NULL
receptors	NULL
,	NULL
although	NULL
they	NULL
apparently	NULL
block	NULL
the	NULL
activation	NULL
pathways	NULL
generated	NULL
by	NULL
the	NULL
activating	NULL
receptors	NULL
.	NULL
``	NULL

''	NULL
As	NULL
a	NULL
working	NULL
hypothesis	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
such	NULL
blocking	NULL
occurs	NULL
at	NULL
the	NULL
very	NULL
early	NULL
stages	NULL
of	NULL
activation	NULL
and	NULL
we	NULL
are	NULL
currently	NULL
investigating	NULL
whether	NULL
this	NULL
inhibition	NULL
affects	NULL
the	NULL
intracellular	NULL
redox	NULL
state	NULL
of	NULL
activated	NULL
NK	NULL
-cell	NULL
clones	NULL
.	NULL

Independently	NULL
of	NULL
the	NULL
immediate	NULL
lytic	NULL
activity	NULL
mediated	NULL
by	NULL
NK	NULL
cells	NULL
after	NULL
interaction	NULL
with	NULL
specific	NULL
target	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
in	NULL
these	NULL
cells	NULL
may	NULL
be	NULL
of	NULL
special	NULL
relevance	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
tumour	NULL
necrosis	NULL
factor-	NULL
«	NULL
and	NULL
-A	NULL
,	NULL
whose	NULL
genes	NULL
are	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
by	NULL
these	NULL
transcription	NULL
factors	NULL
.	NULL
``	NULL

''	NULL
Besides	NULL
soluble	NULL
mediators	NULL
,	NULL
other	NULL
cell	NULL
surface	NULL
markers	NULL
with	NULL
important	NULL
functions	NULL
in	NULL
NK-cell	NULL
activation	NULL
such	NULL
as	NULL
IL-2R	NULL
,	NULL
``	NULL
CD69	NULL
,	NULL
``	NULL
intracellular	NULL
adhesion	NULL
molecule-1	NULL
,	NULL
'*	NULL
``	NULL
and	NULL
other	NULL
integrins	NULL
involved	NULL
in	NULL
cell	NULL
adhesion'*	NULL
may	NULL
be	NULL
also	NULL
regulated	NULL
by	NULL
NF-B	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
this	NULL
transcription	NULL
factor	NULL
is	NULL
essential	NULL
for	NULL
cytotoxic	NULL
cells	NULL
to	NULL
acquire	NULL
a	NULL
fully	NULL
activated	NULL
phenotype	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
CICYT	NULL
SAF	NULL
95/0474	NULL
to	NULL
E.M.	NULL
,	NULL
FIS	NULL
1169/05	NULL
to	NULL
J.P.	NULL
,	NULL
and	NULL
FIS	NULL
1591/94	NULL
to	NULL
R.S	NULL
.	NULL

,	NULL
M.V.B	NULL
.	NULL

is	NULL
a	NULL
fellow	NULL
from	NULL
Fundacion	NULL
Cajasur-Reina	NULL
Sofia	NULL
(	NULL
Cordoba	NULL
,	NULL
Spain	NULL
)	NULL
and	NULL
LL	NULL
.	NULL

is	NULL
a	NULL
fellow	NULL
of	NULL
the	NULL
Ministerio	NULL
de	NULL
Sanidad	NULL
(	NULL
FIS	NULL
)	NULL
(	NULL
Spain	NULL
)	NULL
.	NULL

The	NULL
authors	NULL
wish	NULL
to	NULL
thank	NULL
Drs	NULL
Alain	NULL
Israel	NULL
(	NULL
Institut	NULL
Pasteur	NULL
,	NULL
Paris	NULL
)	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
the	NULL
NF-xB	NULL
antiserum	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Lopez	NULL
De	NULL
Castro	NULL
(	NULL
Madrid	NULL
)	NULL
for	NULL
the	NULL
C1R	NULL
cells	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Esteban	NULL
Tarrades	NULL
for	NULL
the	NULL
photographic	NULL
work	NULL
.	NULL

460	NULL
10	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

REFERENCES	NULL
.	NULL

TrinckieRI	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Biology	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Adv	NULL
Immuno	NULL
!	NULL

47	NULL
,	NULL
187.	NULL
.	NULL

MorEtTA	NULL
L.	NULL
,	NULL
Ciccone	NULL
E.	NULL
,	NULL
Mingarit	NULL
MC	NULL
.	NULL

,	NULL
R.	NULL
&	NULL
MoretTaA	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Human	NULL
natural	NULL
killer	NULL
cells	NULL
:	NULL
origin	NULL
,	NULL
clonality	NULL
,	NULL
specificity	NULL
,	NULL
and	NULL
receptors	NULL
.	NULL

Adv	NULL
Immunol	NULL
55	NULL
,	NULL
341.	NULL
.	NULL

LaNIER	NULL
LL	NULL
.	NULL

,	NULL
RuitenBERG	NULL
J.J.	NULL
&	NULL
PHituips	NULL
J.H	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Functional	NULL
and	NULL
biochemical	NULL
analysis	NULL
of	NULL
CD16	NULL
antigen	NULL
on	NULL
natural	NULL
killer	NULL
cells	NULL
and	NULL
granulocytes	NULL
.	NULL

J	NULL
Immunol	NULL
141	NULL
,	NULL
3478.	NULL
.	NULL

R.L	NULL
.	NULL

,	NULL
RoozEmMonD	NULL
R.C	NULL
.	NULL

&	NULL
van	NULL
DE	NULL
GRIEND	NULL
R.J.	NULL
(	NULL
1986	NULL
)	NULL
Induction	NULL
and	NULL
blocking	NULL
of	NULL
cytolysis	NULL
in	NULL
CD2*	NULL
,	NULL
CD3~	NULL
NK	NULL
and	NULL
CD2*	NULL
,	NULL
CD3+*	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
via	NULL
CD2	NULL
50	NULL
kD	NULL
sheep	NULL
erythrocyte	NULL
receptor	NULL
.	NULL

J	NULL
Immunol	NULL
136	NULL
,	NULL
3939.	NULL
.	NULL

Young	NULL
J.D.-E.	NULL
,	NULL
HeNcartNeR®	NULL
H.	NULL
,	NULL
Popack	NULL
ER	NULL
.	NULL

&	NULL
Comn	NULL
ZA	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Purification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
cytolytic	NULL
pore-forming	NULL
protein	NULL
from	NULL
granules	NULL
of	NULL
cloned	NULL
lymphocytes	NULL
with	NULL
natural	NULL
killer	NULL
activity	NULL
.	NULL

Cell	NULL
44	NULL
,	NULL
849.	NULL
.	NULL

HappaD	NULL
P.	NULL
,	NULL
JennE	NULL
D.E	NULL
.	NULL

,	NULL
KranenBuHL	NULL
O	NULL
.	NULL

&	NULL
TscHopp	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Structure	NULL
and	NULL
possible	NULL
functions	NULL
of	NULL
lymphocyte	NULL
granzymes	NULL
.	NULL

In	NULL
:	NULL
Cytotoxic	NULL
Cells	NULL
:	NULL
Recognition	NULL
,	NULL
Effector	NULL
Function	NULL
,	NULL
Generation	NULL
,	NULL
and	NULL
Methods	NULL
,	NULL
(	NULL
eds	NULL
.	NULL

MV	NULL
.	NULL

Sitkovsky	NULL
&	NULL
PA.	NULL
Henkart	NULL
)	NULL
p.	NULL
251	NULL
.	NULL

Birkhauser	NULL
,	NULL
Boston	NULL
.	NULL

.	NULL

SH1	NULL
L.	NULL
,	NULL
KRAUT	NULL
RP	NULL
.	NULL

,	NULL
AEBERSOLD	NULL
R.	NULL
&	NULL
GREENBERG	NULL
A.H.	NULL
(	NULL
1992	NULL
)	NULL
A	NULL
natural	NULL
killer	NULL
cell	NULL
granule	NULL
protein	NULL
that	NULL
induces	NULL
DNA	NULL
fragmentation	NULL
and	NULL
apoptosis	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
175	NULL
,	NULL
553.	NULL
.	NULL

Lowin	NULL
B.	NULL
,	NULL
Hang	NULL
M.	NULL
,	NULL
MattMan	NULL
C.	NULL
&	NULL
TscHore	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cytolytic	NULL
T-cell	NULL
cytotoxicity	NULL
is	NULL
mediated	NULL
through	NULL
perforin	NULL
and	NULL
Fas	NULL
lytic	NULL
pathways	NULL
.	NULL

Nature	NULL
370	NULL
,	NULL
650.	NULL
.	NULL

PETERS	NULL
P.M.	NULL
,	NULL
ORTALDO	NULL
R.J.	NULL
,	NULL
SHALABY	NULL
MR.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Natural	NULL
killer-sensitive	NULL
targets	NULL
stimulate	NULL
production	NULL
of	NULL
TNF-alpha	NULL
but	NULL
not	NULL
TNF-beta	NULL
(	NULL
lymphotoxin	NULL
)	NULL
by	NULL
highly	NULL
purified	NULL
human	NULL
peripheral	NULL
blood	NULL
large	NULL
granular	NULL
lymphocytes	NULL
.	NULL

J	NULL
Immunol	NULL
137	NULL
,	NULL
2592	NULL
.	NULL

Emsranr	NULL
K.J	NULL
.	NULL

,	NULL
Asraxam	NULL
RT	NULL
.	NULL

,	NULL
BinstaDt	NULL
B.A	NULL
.	NULL

,	NULL
UEHARa	NULL
Y	NULL
.	NULL

&	NULL
Lesson	NULL
P.J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
provides	NULL
an	NULL
early	NULL
and	NULL
requisite	NULL
signal	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
natural	NULL
killer	NULL
cell	NULL
cytotoxic	NULL
function	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88	NULL
,	NULL
6279.	NULL
.	NULL

Chow	NULL
S.C.	NULL
,	NULL
No	NULL
J.	NULL
,	NULL
NorpstEDT	NULL
C.	NULL
,	NULL
FREpHOLM	NULL
B.B	NULL
.	NULL

&	NULL
JonpaL	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Phosphoinositide	NULL
breakdown	NULL
and	NULL
evidence	NULL
for	NULL
protein	NULL
kinase	NULL
C	NULL
involvement	NULL
during	NULL
human	NULL
NK	NULL
killing	NULL
.	NULL

Cell	NULL
Immuno	NULL
!	NULL

114	NULL
,	NULL
96.	NULL
.	NULL

Epwarps	NULL
B.S	NULL
.	NULL

,	NULL
NoLLa	NULL
H.A	NULL
.	NULL

&	NULL
Horrman	NULL
RR	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Relationship	NULL
between	NULL
target	NULL
cell	NULL
recognition	NULL
and	NULL
temporal	NULL
fluctuations	NULL
in	NULL
intracellular	NULL
Ca**	NULL
of	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

J	NULL
Immuno	NULL
!	NULL

143	NULL
,	NULL
1058	NULL
.	NULL

Epwarps	NULL
B.S	NULL
.	NULL

,	NULL
HOFFMAN	NULL
RR	NULL
.	NULL

&	NULL
Curry	NULL
M.S	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Calcium	NULL
mobilization-associated	NULL
and	NULL
independent	NULL
cytosolic	NULL
acidification	NULL
elicited	NULL
in	NULL
tandem	NULL
with	NULL
Na*/H*	NULL
exchanger	NULL
activation	NULL
in	NULL
target	NULL
cell-adherent	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
!	NULL

150	NULL
,	NULL
4766	NULL
.	NULL

Sen	NULL
R.	NULL
&	NULL
Bartimore	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
sequences	NULL
.	NULL

Cell	NULL
46	NULL
,	NULL
705	NULL
.	NULL

Gricut	NULL
M.	NULL
,	NULL
J.J.S	NULL
.	NULL

&	NULL
Lenarpo	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
NF-kappa-B	NULL
and	NULL
rel	NULL
:	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
Rev	NULL
Cytol	NULL
143	NULL
,	NULL
1.	NULL
.	NULL

Finco	NULL
T.S	NULL
.	NULL

&	NULL
Batowin	NULL
A.S.	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Mechanistic	NULL
aspects	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
regulation	NULL
:	NULL
the	NULL
emerging	NULL
role	NULL
of	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
.	NULL

Immunity	NULL
3	NULL
,	NULL
263.	NULL
.	NULL

VERMA	NULL
LLM	NULL
.	NULL

,	NULL
STEVENSON	NULL
J.K.	NULL
,	NULL
ScHwaRrZz	NULL
E.M.	NULL
,	NULL
Van	NULL
Antwerp	NULL
D.	NULL
&	NULL
Miyamoto	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Rel/NF-	NULL
«	NULL
B/IKB	NULL
family	NULL
:	NULL
intimate	NULL
tales	NULL
of	NULL
association	NULL
and	NULL
dissociation	NULL
.	NULL

Genes	NULL
Dev	NULL
9	NULL
,	NULL
2723	NULL
.	NULL

IsraEL	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
A	NULL
role	NULL
for	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
in	NULL
the	NULL
controls	NULL
of	NULL
NF-kappa-B	NULL
activity	NULL
.	NULL

Trends	NULL
Genet	NULL
11	NULL
,	NULL
203	NULL
.	NULL

Meyer	NULL
M.	NULL
,	NULL
ScurEck	NULL
R.	NULL
&	NULL
BaEueRLE	NULL
PA.	NULL
(	NULL
1993	NULL
)	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
antioxidants	NULL
have	NULL
opposite	NULL
effects	NULL
on	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

M.	NULL
Valle-Blazquez	NULL
et	NULL
al	NULL
.	NULL

AP-1	NULL
in	NULL
intact	NULL
cells	NULL
:	NULL
AP-1	NULL
as	NULL
secondary	NULL
antioxidant-responsive	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
12	NULL
,	NULL
2005	NULL
.	NULL

TRAENCKNER	NULL
E.B.-M.	NULL
,	NULL
Wik	NULL
S.	NULL
&	NULL
BaruErRLE	NULL
PA.	NULL
(	NULL
1994	NULL
)	NULL
A	NULL
proteasome	NULL
inhibitor	NULL
prevents	NULL
activation	NULL
of	NULL
NF-KB	NULL
and	NULL
stabilizes	NULL
a	NULL
newly	NULL
phosphorylated	NULL
form	NULL
of	NULL
IK	NULL
Ba	NULL
that	NULL
is	NULL
still	NULL
bound	NULL
to	NULL
NF-xB	NULL
.	NULL

EMBO	NULL
J	NULL
13	NULL
,	NULL
5433	NULL
.	NULL

CuEn	NULL
J.Z	NULL
.	NULL

,	NULL
ParENT	NULL
L.	NULL
&	NULL
Maniatis	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Site-specific	NULL
phosphorylation	NULL
of	NULL
IK	NULL
Bx	NULL
by	NULL
a	NULL
novel	NULL
ubiquitination-dependent	NULL
protein	NULL
kinase	NULL
activity	NULL
.	NULL

Cell	NULL
84	NULL
,	NULL
853	NULL
.	NULL

Rice	NULL
N.R	NULL
.	NULL

,	NULL
MackicHan	NULL
M.L	NULL
.	NULL

&	NULL
Israft	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
The	NULL
precursor	NULL
of	NULL
NF-xB	NULL
p50	NULL
has	NULL
IKB-like	NULL
functions	NULL
.	NULL

Cell	NULL
71	NULL
,	NULL
243	NULL
.	NULL

Rosertson	NULL
M.J.	NULL
,	NULL
Maney	NULL
TJ	NULL
.	NULL

,	NULL
Donanue	NULL
C.	NULL
,	NULL
Levine	NULL
H.	NULL
&	NULL
Ritz	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Costimulatory	NULL
signals	NULL
are	NULL
required	NULL
for	NULL
optimal	NULL
proliferation	NULL
of	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
150	NULL
,	NULL
1705	NULL
.	NULL

ScuEnk	NULL
H.	NULL
,	NULL
Kuem	NULL
M.	NULL
,	NULL
ErpsrRUGGER	NULL
W.	NULL
,	NULL
Drooe	NULL
W.	NULL
&	NULL
OstHorr	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Distinct	NULL
effects	NULL
of	NULL
thioredoxin	NULL
and	NULL
antioxidants	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91	NULL
,	NULL
1672	NULL
.	NULL

Hengket	NULL
T.	NULL
,	NULL
MacHLEIDT	NULL
T.	NULL
,	NULL
AuKkaLay	NULL
I.	NULL
,	NULL
KronkE	NULL
M.	NULL
,	NULL
Ben-HeRIAK	NULL
Y	NULL
.	NULL

&	NULL
BaEuERLE	NULL
P.A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Rapid	NULL
proteolysis	NULL
of	NULL
IK	NULL
Bx	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

Nature	NULL
365	NULL
,	NULL
182	NULL
.	NULL

WHitesipe	NULL
S.T	NULL
.	NULL

,	NULL
Ernst	NULL
MK	NULL
.	NULL

,	NULL
LeBai	NULL
O.	NULL
,	NULL
Laurent-WintER	NULL
C.	NULL
,	NULL
Rice	NULL
N.	NULL
&	NULL
IsraEL	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
N-	NULL
and	NULL
C-Terminal	NULL
sequences	NULL
control	NULL
degradation	NULL
of	NULL
MAD3/1xBa	NULL
in	NULL
response	NULL
to	NULL
inducers	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15	NULL
,	NULL
5339	NULL
.	NULL

B	NULL
.	NULL

&	NULL
GuTrtERIDGE	NULL
J.M.C	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Free	NULL
Radicals	NULL
in	NULL
Biology	NULL
and	NULL
Medicine	NULL
.	NULL

edn	NULL
2	NULL
Clarendon	NULL
Press	NULL
,	NULL
Oxford	NULL
.	NULL

YAMAUCHI	NULL
A	NULL
.	NULL

&	NULL
Broom	NULL
ET	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Requirement	NULL
of	NULL
thiol	NULL
compounds	NULL
as	NULL
reducing	NULL
agents	NULL
for	NULL
IL-2	NULL
mediated	NULL
induction	NULL
of	NULL
LAK	NULL
activity	NULL
and	NULL
proliferation	NULL
of	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

J	NULL
Immuno	NULL
!	NULL

151	NULL
,	NULL
5535	NULL
.	NULL

Epwarps	NULL
B.S	NULL
.	NULL

,	NULL
Meraitt	NULL
J.A	NULL
.	NULL

,	NULL
JecEN	NULL
P.A	NULL
.	NULL

&	NULL
Borpen	NULL
E.C	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
diethyldithiocarbamate	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
interferon	NULL
antiviral	NULL
activity	NULL
,	NULL
upon	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
132	NULL
,	NULL
2868	NULL
.	NULL

Yokoyama	NULL
W.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Recognition	NULL
structures	NULL
on	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
5	NULL
,	NULL
67	NULL
.	NULL

LaNniEr	NULL
LL	NULL
.	NULL

&	NULL
PHituips	NULL
J.H	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Inhibitory	NULL
MHC	NULL
class	NULL
I	NULL
receptors	NULL
on	NULL
NK	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Immunol	NULL
Today	NULL
17	NULL
,	NULL
86	NULL
.	NULL

CHAMBERS	NULL
W.H	NULL
.	NULL

,	NULL
Vujanovic	NULL
N.L	NULL
.	NULL

,	NULL
Dereo	NULL
A.B	NULL
.	NULL

,	NULL
M.W	NULL
.	NULL

,	NULL
HERBERMAN	NULL
R.B	NULL
.	NULL

&	NULL
HiseropT	NULL
J.C.	NULL
(	NULL
1989	NULL
)	NULL
Monoclonal	NULL
antibody	NULL
to	NULL
a	NULL
triggering	NULL
structure	NULL
expressed	NULL
on	NULL
rat	NULL
natural	NULL
killer	NULL
cells	NULL
and	NULL
adherence	NULL
lymphokine-activated	NULL
killer	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
169	NULL
,	NULL
1373	NULL
.	NULL

NEwMAN	NULL
W.	NULL
,	NULL
Fast	NULL
LD	NULL
.	NULL

&	NULL
Rose	NULL
LM	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Blockade	NULL
of	NULL
NK	NULL
cell	NULL
lysis	NULL
is	NULL
a	NULL
property	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
that	NULL
bind	NULL
to	NULL
distinct	NULL
regions	NULL
of	NULL
T-200	NULL
,	NULL
J	NULL
Immunol	NULL
131	NULL
,	NULL
1742	NULL
.	NULL

Belt	NULL
G.M	NULL
.	NULL

,	NULL
Deturorr	NULL
G.M	NULL
.	NULL

&	NULL
ImBopeN	NULL
J.B.	NULL
(	NULL
1993	NULL
)	NULL
CD45-negative	NULL
mutants	NULL
of	NULL
a	NULL
rat	NULL
natural	NULL
killer	NULL
cell	NULL
line	NULL
fail	NULL
to	NULL
lyse	NULL
tumor	NULL
target	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
151	NULL
,	NULL
3646	NULL
.	NULL

Menon	NULL
S.D	NULL
.	NULL

,	NULL
Guy	NULL
RD	NULL
.	NULL

&	NULL
Tan	NULL
Y.H	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Involvement	NULL
of	NULL
a	NULL
putative	NULL
tyrosine	NULL
phosphatase	NULL
and	NULL
I-kappa	NULL
Ba	NULL
serine	NULL
phosphorylation	NULL
in	NULL
nuclear	NULL
factor	NULL
kappa-B	NULL
activation	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270	NULL
,	NULL
18881	NULL
.	NULL

SmoH	NULL
S.	NULL
&	NULL
AccarwaLr	NULL
B.B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Protein	NULL
tyrosine	NULL
phosphatase	NULL
inhibitors	NULL
block	NULL
tumor	NULL
necrosis	NULL
factor	NULL
dependent	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
transcription	NULL
factor	NULL
NF-Kappa	NULL
B.	NULL
J	NULL
Biol	NULL
Chem	NULL
270	NULL
,	NULL
10631	NULL
.	NULL

BURSHTYN	NULL
D.N	NULL
.	NULL

,	NULL
SCHARENBERG	NULL
A.M.	NULL
,	NULL
WAGTMANN	NULL
N.	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Recruitment	NULL
of	NULL
tyrosine	NULL
phosphatase	NULL
HCP	NULL
by	NULL
the	NULL
killer	NULL
cell	NULL
inhibitory	NULL
receptor	NULL
.	NULL

Immunity	NULL
4	NULL
,	NULL
77	NULL
.	NULL

Loprez-CaBrEra	NULL
M.	NULL
,	NULL
MuKRoz	NULL
E.	NULL
,	NULL
Brazquez	NULL
MV	NULL
.	NULL

,	NULL
Ursa	NULL
M.A	NULL
.	NULL

,	NULL
Santis	NULL
A.G.	NULL
&	NULL
SancHEz-Maparip	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
human	NULL
c-type	NULL
lectin	NULL
leukocyte	NULL
receptor	NULL
AIM/CD69	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
its	NULL
tumor	NULL
necrosis	NULL
factor-x-responsive	NULL
elements	NULL
.	NULL

J	NULL
Bio/	NULL
Chem	NULL
270	NULL
,	NULL
21545	NULL
.	NULL

©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
90	NULL
,	NULL
455-460	NULL

